semaglutide vs tirzepatide which is better for weight loss Tirzepatide: GLP-1 Wins Loss? Semaglutide vs Tirzepatide: Which Is

The synthetic form of exendin-4, known as exenatide , became the first GLP-1 receptor agonist licensed for clinical use in the EU in 2006

Zepbound (tirzepatide) is a dual GLP-1 and GIP receptor agonist approved for weight loss, and clinical trials show that gastrointestinal symptomsincluding heartburn and acid refluxoccur in 20-30% of users

Note: If you are ever unsure about the appearance of your medication, contact your healthcare provider or the pharmacy that dispensed it

At higher doses (1015 mg): Stay in regular contact with your prescriber

After you think you are finished, wait 10-15 seconds and try again

As GLP-1s expand their indications, pressure is building on payors to reassess reimbursement policies